BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15535290)

  • 1. [Pathology of ovarian cancer].
    Kaku T; Ogawa S; Hirakawa T; Ohishi Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():471-5. PubMed ID: 15535290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology of ovarian cancer].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
    [No Abstract]   [Full Text] [Related]  

  • 3. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytology of ovarian epithelial tumors].
    Otsuki T; Yaegashi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():503-6. PubMed ID: 15535296
    [No Abstract]   [Full Text] [Related]  

  • 5. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
    Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological diagnosis of ovarian cancer].
    Yamabe H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endometrioid adenocarcinoma of the uterine cervix associated with mucinous ovarian cystadenocarcinoma].
    Ferchichi L; Rammeh-Rommani S; Ben Hammouda S; Sfar R; Farah F; Ben Jilani S; Zermani R
    Gynecol Obstet Fertil; 2006 May; 34(5):410-2. PubMed ID: 16677843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTF-1 expression in primary ovarian epithelial neoplasia.
    Graham AD; Williams AR; Salter DM
    Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of ovarian cancer associated with endometriosis.
    Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
    Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of ovarian lesions: the intraoperative approach.
    Jiménez-Ayala M; Jiménez-Ayala Portillo B
    Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].
    Antoneeva II
    Vopr Onkol; 2007; 53(4):393-5. PubMed ID: 17969399
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent developments in the pathology of ovarian epithelial tumors of low malignant potential and related neoplasms.
    Michael H; Roth LM; Kotylo PK
    Pathol Annu; 1993; 28 Pt 2():1-22. PubMed ID: 8395042
    [No Abstract]   [Full Text] [Related]  

  • 14. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
    Mutch DG; Prat J
    Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.
    Zhou F; Cao X; Liu M; Wang Y; Tao G
    Clin Lab; 2011; 57(5-6):421-4. PubMed ID: 21755835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Hsieh DS; Loh SH; Chen A; Yao CW; Yen CY
    Mod Pathol; 2006 Mar; 19(3):447-52. PubMed ID: 16439987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
    Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological diagnosis of endometrial cancer in biopsy specimen].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():362-6. PubMed ID: 23156271
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.